Search research articles
Contact Us
Filters
Showing results (31-40 of 170) with videos related to
Page
of 17
Sort By:
Annals of Gastroenterology
|
November 10, 2017
The effectiveness of intravenous iron for iron deficiency anemia in gastrointestinal cancer patients: a retrospective study
Laurens Verhaeghe, Luk Bruyneel, Elisabeth Stragier, et al.
Radiology and Oncology
|
June 2, 2016
Tenckhoff tunneled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome
Geert Maleux, Inge Indesteege, Annouschka Laenen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2010
Lessons from the adjuvant bevacizumab trial on colon cancer: what next?
Eric Van Cutsem, Diether Lambrechts, Hans Prenen, et al.
Clinical Pharmacology : Advances and Applications
|
August 18, 2020
Dose Regimen Rationale for Panitumumab in Cancer Patients: To Be Based on Body Weight or Not
Michael Z Liao, Marloes Berkhout, Hans Prenen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 14, 2020
High mortality of cancer patients in times of SARS-CoV-2: Do not generalize!
Peter A van Dam, Manon Huizing, Kostantinos Papadimitriou, et al.
Journal of Surgical Oncology
|
December 18, 2010
Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: the role of anti-VEGF and anti-EGFR antibodies
Ravit Geva, Hans Prenen, Baki Topal, et al.
Oncotargets and Therapy
|
February 5, 2013
Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer
Ravit Geva, Loredana Vecchione, Sabine Tejpar, et al.
Anti-Cancer Drugs
|
September 15, 2020
LifePearl microspheres loaded with irinotecan in the treatment of Liver-dominant metastatic colorectal carcinoma: feasibility, safety and pharmacokinetic study
Geert Maleux, Hans Prenen, Thomas Helmberger, et al.
Cancer Management and Research
|
August 9, 2020
Refractory Metastatic Colorectal Cancer: Current Challenges and Future Prospects
Marissa Lam, Caroline Lum, Sarah Latham, et al.
Pharmacological Reviews
|
June 16, 2022
The Nitrogen Mustards
Martin S Highley, Bart Landuyt, Hans Prenen, et al.
Page
of 17
Search research articles
Search
Showing results (31-40 of 170) with videos related to
Sort By:
Page
of 17
Annals of Gastroenterology
|
November 10, 2017
The effectiveness of intravenous iron for iron deficiency anemia in gastrointestinal cancer patients: a retrospective study
Laurens Verhaeghe, Luk Bruyneel, Elisabeth Stragier, et al.
Radiology and Oncology
|
June 2, 2016
Tenckhoff tunneled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome
Geert Maleux, Inge Indesteege, Annouschka Laenen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2010
Lessons from the adjuvant bevacizumab trial on colon cancer: what next?
Eric Van Cutsem, Diether Lambrechts, Hans Prenen, et al.
Clinical Pharmacology : Advances and Applications
|
August 18, 2020
Dose Regimen Rationale for Panitumumab in Cancer Patients: To Be Based on Body Weight or Not
Michael Z Liao, Marloes Berkhout, Hans Prenen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 14, 2020
High mortality of cancer patients in times of SARS-CoV-2: Do not generalize!
Peter A van Dam, Manon Huizing, Kostantinos Papadimitriou, et al.
Journal of Surgical Oncology
|
December 18, 2010
Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: the role of anti-VEGF and anti-EGFR antibodies
Ravit Geva, Hans Prenen, Baki Topal, et al.
Oncotargets and Therapy
|
February 5, 2013
Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer
Ravit Geva, Loredana Vecchione, Sabine Tejpar, et al.
Anti-Cancer Drugs
|
September 15, 2020
LifePearl microspheres loaded with irinotecan in the treatment of Liver-dominant metastatic colorectal carcinoma: feasibility, safety and pharmacokinetic study
Geert Maleux, Hans Prenen, Thomas Helmberger, et al.
Cancer Management and Research
|
August 9, 2020
Refractory Metastatic Colorectal Cancer: Current Challenges and Future Prospects
Marissa Lam, Caroline Lum, Sarah Latham, et al.
Pharmacological Reviews
|
June 16, 2022
The Nitrogen Mustards
Martin S Highley, Bart Landuyt, Hans Prenen, et al.
Page
of 17